The Ozempidemic — is social media telling the full story?
By Dana Douglas | 3 days agoTo strain the surplus of information about GLP-1 medication circulating on social media, The Cavalier Daily spoke to those on the frontlines of the phenomenon — University medical professionals and a student prescribed GLP-1 — to uncover what this development actually looks like for the future of weight management, diabetes treatment and American healthcare as a whole.





















